论文部分内容阅读
目的观察前列舒通胶囊联合盐酸莫西沙星治疗慢性前列腺炎的效果。方法慢性前列腺炎的患者100例,随机分为观察组和对照组各50例。对照组予盐酸莫西沙星治疗,观察组在对照组基础上加用前列舒通胶囊治疗。比较2组治疗前后NIH-CPSI评分及前列腺液白细胞水平与治疗疗效。结果治疗后2组NIH-CPSI评分及前列腺液白细胞水平比较差异有统计学意义(P<0.05)。观察组总有效率为92.0%,高于对照组的74.0%(χ2=7.45,P<0.05)。结论前列舒通胶囊联合盐酸莫西沙星治疗慢性前列腺炎疗效肯定,可明显改善患者症状。值得临床推广应用。
Objective To observe the effect of Qianlieshutong capsule combined with moxifloxacin hydrochloride in the treatment of chronic prostatitis. Methods 100 cases of chronic prostatitis were randomly divided into observation group and control group of 50 cases. The control group was treated with moxifloxacin hydrochloride. The observation group was treated with Qianlieshutong capsule on the basis of the control group. The NIH-CPSI score and prostatic fluid leukocyte level before and after treatment were compared between two groups. Results After treatment, the NIH-CPSI score and the level of prostatic fluid leukocyte in the two groups were significantly different (P <0.05). The total effective rate in the observation group was 92.0%, which was higher than 74.0% in the control group (χ2 = 7.45, P <0.05). Conclusion Qianlieshutong capsule combined with moxifloxacin hydrochloride treatment of chronic prostatitis positive effect, can significantly improve the symptoms of patients. Worthy of clinical application.